{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:30:39Z","timestamp":1788449439189,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.pcad.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T02:14:33Z","timestamp":1653012873000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["MitraClip for secondary mitral regurgitation: Patient selection"],"prefix":"10.1016","volume":"73","author":[{"given":"Sandip K.","family":"Zalawadiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly M.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashish","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2022.05.004_bb0005","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.jacc.2020.02.005","article-title":"2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"75","author":"Bonow","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0010","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","article-title":"Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy","volume":"97","author":"Rossi","year":"2011","journal-title":"Heart."},{"key":"10.1016\/j.pcad.2022.05.004_bb0015","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/heartjnl-2017-312002","article-title":"Secondary mitral regurgitation (part 2): deliberations on mitral surgery and transcatheter repair","volume":"104","author":"Gaasch","year":"2018","journal-title":"Heart."},{"key":"10.1016\/j.pcad.2022.05.004_bb0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/heartjnl-2017-312001","article-title":"Secondary mitral regurgitation (part 1): volumetric quantification and analysis","volume":"104","author":"Gaasch","year":"2018","journal-title":"Heart."},{"key":"10.1016\/j.pcad.2022.05.004_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","article-title":"Mitral-valve repair versus replacement for severe ischemic mitral regurgitation","volume":"370","author":"Acker","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.004_bb0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.004_bb0040","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.004_bb0045","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.112.143818","article-title":"Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial","volume":"126","author":"Chan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2022.05.004_bb0050","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.21037\/jtd.2018.07.07","article-title":"Functional mitral regurgitation: an overview for surgical management framework","volume":"10","author":"Nappi","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.pcad.2022.05.004_bb0055","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.004_bb0060","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.004_bb0065","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.jacc.2015.10.018","article-title":"Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II","volume":"66","author":"Feldman","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0070","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jchf.2019.03.016","article-title":"Neurohormonal and Transcatheter repair strategies for proportionate and disproportionate functional mitral regurgitation in heart failure","volume":"7","author":"Packer","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pcad.2022.05.004_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.119.039612","article-title":"Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure","volume":"140","author":"Packer","year":"2019","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.pcad.2022.05.004_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamacardio.2019.5971","article-title":"New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation","volume":"5","author":"Packer","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ejhf.1469","article-title":"Disproportionate functional mitral regurgitation: a new therapeutic target in patients with heart failure and a reduced ejection fraction","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2022.05.004_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","article-title":"Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials","volume":"12","author":"Grayburn","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2022.05.004_bb0095","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/01.CIR.0000087599.49332.05","article-title":"Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction","volume":"108","author":"Lancellotti","year":"2003","journal-title":"Circulation."},{"issue":"63","key":"10.1016\/j.pcad.2022.05.004_bb0100","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"2014","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0105","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pcad.2022.05.004_bb0110","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2022.05.004_bb0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of Patients with Valvular Heart Disease: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.pcad.2022.05.004_bb0120","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"ESC\/EACTS guidelines for the management of valvular heart disease","volume":"2017","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2022.05.004_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2018.06.041","article-title":"Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy","volume":"269","author":"Godino","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0130","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.amjcard.2017.01.024","article-title":"A risk model for prediction of 1-year mortality in patients undergoing MitraClip implantation","volume":"119","author":"Buccheri","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0135","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jacc.2017.09.015","article-title":"Outcomes with transcatheter mitral valve repair in the United States: an STS\/ACC TVT registry report","volume":"70","author":"Sorajja","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2022.05.004_bb0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamacardio.2019.4428","article-title":"Association of pulmonary hypertension with clinical outcomes of transcatheter mitral valve repair","volume":"5","author":"Al-Bawardy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0145","doi-asserted-by":"crossref","first-page":"e1817","DOI":"10.4244\/EIJ-D-16-00909","article-title":"Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair","volume":"12","author":"Yzeiraj","year":"2017","journal-title":"EuroIntervention."},{"key":"10.1016\/j.pcad.2022.05.004_bb0150","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/joic.12566","article-title":"Impact of right heart function on outcome in patients with functional mitral regurgitation and chronic heart failure undergoing percutaneous edge-to-edge-repair","volume":"31","author":"Osteresch","year":"2018","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ahj.2019.06.015","article-title":"Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: insights from the multicenter GRASP-IT registry","volume":"217","author":"Adamo","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2022.05.004_bb0160","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jcin.2017.07.042","article-title":"Impact of frailty on outcomes in patients undergoing percutaneous mitral valve repair","volume":"10","author":"Metze","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2022.05.004_bb0165","first-page":"90","article-title":"Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation","volume":"11","author":"Godino","year":"2016","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.pcad.2022.05.004_bb0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ejhf.864","article-title":"Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry","volume":"20","author":"Tigges","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2022.05.004_bb0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2020.05.061","article-title":"Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair","volume":"316","author":"Iliadis","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0180","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.amjcard.2017.07.027","article-title":"Relation of residual mitral regurgitation despite elevated mitral gradients to risk of heart failure hospitalization after MitraClip repair","volume":"120","author":"Cheng","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jtcvs.2015.09.099","article-title":"What is a \u201cgood\u201d result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitation","volume":"151","author":"Buzzatti","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2022.05.004_bb0190","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ijcard.2016.10.054","article-title":"Impact of residual mitral regurgitation after MitraClip implantation","volume":"227","author":"Kaneko","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0195","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2022.05.004_bb0200","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Weissman NJ and American Society of E. recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2022.05.004_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native Valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2022.05.004_bb0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0735-1097(98)00236-8","article-title":"Effects of afterload reduction on vena contracta width in mitral regurgitation","volume":"32","author":"Kizilbash","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2022.05.004_bb0220","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.jacc.2019.09.017","article-title":"Echocardiographic outcomes after Transcatheter leaflet approximation in patients with secondary mitral regurgitation: the COAPT trial","volume":"74","author":"Asch","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2022.05.004_bb0225","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ehjci\/jex056","article-title":"Vena contracta area for severity grading in functional and degenerative mitral regurgitation: a transoesophageal 3D colour Doppler analysis in 500 patients","volume":"19","author":"Goebel","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2022.05.004_bb0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_106_19","article-title":"Utility of MitraClip XTR system in percutaneous edge-to-edge mitral valve repair for severe flail leaflet","volume":"21","author":"Al-Hijji","year":"2020","journal-title":"Heart Views"},{"key":"10.1016\/j.pcad.2022.05.004_bb0235","article-title":"(Abstract) Contemporary, real-world, clinical outcomes with the next generation MitraClip (NTR\/XTR): results from the 1040 patient global EXPAND study","author":"Bardeleben","year":"2019","journal-title":"ESC Congress"},{"issue":"6","key":"10.1016\/j.pcad.2022.05.004_bb0240","first-page":"426","article-title":"Relationship between residual mitral regurgitation and clinical and quality-of-life outcomes after Transcatheter and medical treatments in heart failure: the COAPT trial","volume":"144","author":"Kar","year":"2020","journal-title":"Eur J HF"},{"key":"10.1016\/j.pcad.2022.05.004_bb0245","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jcin.2019.03.023","article-title":"Edge-to-edge mitral valve repair with extended clip arms: early experience from a multicenter observational study","volume":"12","author":"Praz","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2022.05.004_bb0250","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004856","article-title":"Acute changes in left atrial pressure after MitraClip are associated with improvement in 6-minute walk distance","volume":"10","author":"Maor","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2022.05.004_bb0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcin.2018.07.051","article-title":"Continuous direct left atrial pressure: Intraprocedural measurement predicts clinical response following MitraClip therapy","volume":"12","author":"Kuwata","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2022.05.004_bb0260","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007315","article-title":"Mitral valve anatomic predictors of hemodynamic success with transcatheter mitral valve repair","volume":"7","author":"Thaden","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2022.05.004_bb0265","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011366","article-title":"Elevated mitral valve pressure gradient is predictive of long-term outcome after percutaneous edge-to-edge mitral valve repair in patients with degenerative mitral regurgitation (MR), but not in functional MR","volume":"8","author":"Patzelt","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2022.05.004_bb0270","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.21037\/jtd.2019.12.137","article-title":"New developments in transcatheter therapy of mitral valve disease","volume":"12","author":"Walther","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.pcad.2022.05.004_bb0275","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcin.2019.04.034","article-title":"Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study","volume":"12","author":"Lim","year":"2019","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062022000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:19:50Z","timestamp":1758500390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062022000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":55,"alternative-id":["S0033062022000470"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2022.05.004","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MitraClip for secondary mitral regurgitation: Patient selection","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}